Increased platelet distribution width predicts poor prognosis in melanoma patients
- PMID: 28592835
- PMCID: PMC5462764
- DOI: 10.1038/s41598-017-03212-y
Increased platelet distribution width predicts poor prognosis in melanoma patients
Abstract
Activated platelets promote cancer progression and metastasis. Nevertheless, the prognostic value of platelet indices in melanoma had been rarely reported. The aim of this study was to investigate the predictive significance of platelet indices in melanoma. A total of 220 consecutive patients with melanoma were retrospectively enrolled between January 2009 and December 2009. The relationship between PDW and clinicopathological characteristics were analyzed. Kaplan-Meier method and Cox regression were used to evaluate the prognostic impact of PDW. Of the 220 patients, high platelet distribution width (PDW) levels were observed in 63 (28.6%) patients. Increased PDW was associated with tumor subtype (P < 0.001). Survival curves found that patients with increased PDW had significantly shorter survival time than those with normal PDW (P < 0.001). Cox regression analysis revealed that elevated PDW was an independent prognostic factor for overall survival (hazard ratio, 2.480; 95% confidence interval [CI], 1.386-4.436, P = 0.002). In conclusion, PDW is easily available in routine blood test. Our findings indicated that PDW is an independent predictor and that it may also be a potential parameter for targeted therapy in melanoma.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Higher platelet distribution width predicts poor prognosis in laryngeal cancer.Oncotarget. 2017 Jul 18;8(29):48138-48144. doi: 10.18632/oncotarget.18306. Oncotarget. 2017. PMID: 28624815 Free PMC article.
-
Elevated platelet distribution width predicts poor prognosis in hepatocellular carcinoma.Cancer Biomark. 2019;24(3):307-313. doi: 10.3233/CBM-182076. Cancer Biomark. 2019. PMID: 30829614
-
Platelet distribution width correlates with prognosis of non-small cell lung cancer.Sci Rep. 2017 Jun 14;7(1):3456. doi: 10.1038/s41598-017-03772-z. Sci Rep. 2017. PMID: 28615714 Free PMC article.
-
Decreased platelet distribution width predicts a worse prognosis in patients undergoing surgical resection for hepatocellular carcinoma.Cancer Biomark. 2019;26(3):361-366. doi: 10.3233/CBM-190474. Cancer Biomark. 2019. PMID: 31594211
-
Elevated preoperative platelet distribution width predicts poor prognosis in Esophageal Squamous Cell Carcinoma.Sci Rep. 2019 Oct 23;9(1):15234. doi: 10.1038/s41598-019-51675-y. Sci Rep. 2019. PMID: 31645619 Free PMC article.
Cited by
-
Mean platelet volume and platelet distribution width serve as prognostic biomarkers in skull base chordoma: a retrospective study.BMC Cancer. 2020 Oct 12;20(1):988. doi: 10.1186/s12885-020-07497-7. BMC Cancer. 2020. PMID: 33046024 Free PMC article.
-
The role of platelets in the regulation of tumor growth and metastasis: the mechanisms and targeted therapy.MedComm (2020). 2023 Sep 14;4(5):e350. doi: 10.1002/mco2.350. eCollection 2023 Oct. MedComm (2020). 2023. PMID: 37719444 Free PMC article. Review.
-
Increased Platelet Distribution Width Predicts 3-Year Recurrence in Patients with Hepatocellular Carcinoma After Surgical Resection.Cancer Manag Res. 2023 Jun 14;15:501-509. doi: 10.2147/CMAR.S408548. eCollection 2023. Cancer Manag Res. 2023. PMID: 37337478 Free PMC article.
-
Prognostic value of inflammation-based indices in patients with resected hepatocellular carcinoma.BMC Cancer. 2021 Apr 27;21(1):469. doi: 10.1186/s12885-021-08153-4. BMC Cancer. 2021. PMID: 33906632 Free PMC article.
-
Cell-Mediated Release of Nanoparticles as a Preferential Option for Future Treatment of Melanoma.Cancers (Basel). 2020 Jul 2;12(7):1771. doi: 10.3390/cancers12071771. Cancers (Basel). 2020. PMID: 32630815 Free PMC article. Review.
References
-
- Suzuki K, et al. Platelets counts closely correlate with the disease-free survival interval of pancreatic cancer patients. Hepatogastroenterology. 2004;51(57):847–853. - PubMed
-
- Pietrzyk L, et al. Diagnostic Power of Blood Parameters as Screening Markers in Gastric Cancer Patients. Asian Pac. J. Cancer Prev. 2016;17(9):4433–4437. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical